United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$76Mraised across 6 rounds since 2010, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $16M sold, first sale Aug 2015
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Jun 2015
From a historical funding recordSEC filing: $27M sold, first sale Mar 2014
No investor was named in the report.
Reported by genomeweb.comSEC filing: $6.5M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Aug 2012
From Exosome Diagnostics's own website and the SEC filings it signed: 15 on the team.
On the board, as filediGeert-Jan MulderJoseph SlatteryKapil DhingraPeter JohannSteven Soignet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Forbion Capital PartnersNGN CapitalArcus Venturesb-to-v Partners AGCD-Venture
Tiger Management Corporation
QiagenMissing a round, or an investor who was in one? Tell us.
Exosome Diagnostics's investors include Forbion Capital Partners, NGN Capital, Arcus Ventures, b-to-v Partners AG and CD-Venture, and 2 more on record.
Exosome Diagnostics has raised $76M across 6 rounds since 2010.
Exosome Diagnostics's most recent round was a Series B of $18M in Sept 2015.
Exosome Diagnostics's largest round on record is $27M (Series B), in Mar 2014.
Exosome Diagnostics's first round on record, in May 2010, was backed by Forbion Capital Partners and NGN Capital.
Exosome Diagnostics's latest named round is a Series B, in Sept 2015.
Exosome Diagnostics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
